Overview
Acquired chylothorax is a rare condition characterized by the accumulation of chyle in the pleural space, often resulting from thoracic duct injury or dysfunction 1.Diagnosis
Clinical Presentation: Presence of chylous pleural effusion confirmed by triglyceride levels >110 mg/dL 1.
Imaging: Chest CT may reveal pleural effusion with characteristic fat density 1.
Advanced Imaging: Dynamic contrast-enhanced magnetic resonance lymphangiography can delineate lymphatic anatomy and identify abnormal pathways 1.Management
First-Line Treatments:
- Dietary Modifications: Low-fat diet to reduce chyle production 1.
- Thoracic Duct Ligation: Surgical intervention for persistent cases 1.
Adjunctive Treatments:
- Percutaneous Lymphatic Embolization: Guided by advanced imaging techniques, effective in refractory cases 1.Special Populations
No Specific Data Provided: Abstracts do not cover management specifics for pregnancy, pediatrics, elderly, or comorbidities 1.Key Recommendations
Consider dynamic contrast-enhanced magnetic resonance lymphangiography for delineating lymphatic anatomy in refractory cases of chyloptysis or chylothorax (Evidence: Moderate) 1.
Percutaneous lymphatic embolization guided by imaging can be an effective adjunctive treatment for patients who fail conservative management and thoracic duct ligation (Evidence: Weak) 1.
Implement dietary modifications with a low-fat diet as initial management for acquired chylothorax (Evidence: Expert opinion) 1.References
1 Chick JFB, Nadolski GJ, Lanfranco AR, Haas A, Itkin M. Dynamic Contrast-Enhanced Magnetic Resonance Lymphangiography and Percutaneous Lymphatic Embolization for the Diagnosis and Treatment of Recurrent Chyloptysis. Journal of vascular and interventional radiology : JVIR 2019. link